PolarityBio is a late-stage biotechnology company preparing to launch SkinTE, an investigational regenerative multicellular biologic made from a patient’s own skin. SkinTE is under FDA review as a physician-administered Section 351 biologic (BLA) for chronic wounds, with an anticipated initial indication of Wagner 1 diabetic foot ulcers. The Director, Market Access owns the coding, coverage, and payment strategy to support provider and patient access to SkinTE at launch and beyond. This hands-on leadership role focuses on payer strategy, coverage, payment, and payer contracting, and also includes Medicare Administrative Contractor engagement, reimbursement operations, vendor oversight, and leadership of the field reimbursement team. The director sets and leads the access strategy, with specialist vendor partners supporting execution. The role requires understanding ASP-based payment, provider economics, and SkinTE’s parallel coding pathways: Category III CPT codes 1044T–1049T for harvest and application procedures, and a product-specific HCPCS Level II J-code for the biologic. The director works closely with Commercial, Medical, Regulatory, and Legal and has significant influence over launch readiness. The role is full-time, exempt, and remote in North America, with travel as needed for payer, provider, and conference engagements.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director